These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 21167718)
1. Treatment of persistent and recurrent acromegaly. Del Porto LA; Liubinas SV; Kaye AH J Clin Neurosci; 2011 Feb; 18(2):181-90. PubMed ID: 21167718 [TBL] [Abstract][Full Text] [Related]
2. The place of medical treatment of acromegaly: current status and perspectives. Jallad RS; Bronstein MD Expert Opin Pharmacother; 2013 Jun; 14(8):1001-15. PubMed ID: 23600991 [TBL] [Abstract][Full Text] [Related]
3. Pituitary tumours: acromegaly. Chanson P; Salenave S; Kamenicky P; Cazabat L; Young J Best Pract Res Clin Endocrinol Metab; 2009 Oct; 23(5):555-74. PubMed ID: 19945023 [TBL] [Abstract][Full Text] [Related]
4. Therapy for the syndromes of GH excess. Arosio M; Cannavò S; Epaminonda P; Ronchi C; Chiodini I; Adda G J Endocrinol Invest; 2003; 26(10 Suppl):36-43. PubMed ID: 15497658 [TBL] [Abstract][Full Text] [Related]
5. Acromegaly. Scacchi M; Cavagnini F Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948 [TBL] [Abstract][Full Text] [Related]
6. [Advances in the treatment of acromegaly]. Krysiak R; Okopień B; Marek B Pol Merkur Lekarski; 2008 Jan; 24(139):59-65. PubMed ID: 18634256 [TBL] [Abstract][Full Text] [Related]
8. [Current diagnosis and treatment of acromegaly]. Melgar V; Espinosa E; Cuenca D; Valle V; Mercado M Rev Med Inst Mex Seguro Soc; 2015; 53(1):74-83. PubMed ID: 25680646 [TBL] [Abstract][Full Text] [Related]
9. Pituitary tumors. Mehta GU; Jane JA Curr Opin Neurol; 2012 Dec; 25(6):751-5. PubMed ID: 23108246 [TBL] [Abstract][Full Text] [Related]
10. LIMITATIONS OF CURRENT APPROACHES FOR THE TREATMENT OF ACROMEGALY. Shanik MH Endocr Pract; 2016 Feb; 22(2):210-9. PubMed ID: 26437214 [TBL] [Abstract][Full Text] [Related]
11. Treatment outcomes and mortality of 94 patients with acromegaly. Trepp R; Stettler C; Zwahlen M; Seiler R; Diem P; Christ ER Acta Neurochir (Wien); 2005 Mar; 147(3):243-51; discussion 250-1. PubMed ID: 15627919 [TBL] [Abstract][Full Text] [Related]
12. New formulations and approaches in the medical treatment of acromegaly. Debono M; Newell-Price J Curr Opin Endocrinol Diabetes Obes; 2010 Aug; 17(4):350-5. PubMed ID: 20502324 [TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes of patients with acromegaly: a report from the Swedish Pituitary Register. Arnardóttir S; Järås J; Burman P; Berinder K; Dahlqvist P; Erfurth EM; Höybye C; Larsson K; Ragnarsson O; Ekman B; Edén Engström B Eur J Endocrinol; 2022 Feb; 186(3):329-339. PubMed ID: 35007208 [TBL] [Abstract][Full Text] [Related]
14. Absence of immunostaining for growth hormone in a subset of patients with acromegaly. Schroeder JL; Spiotta AM; Fleseriu M; Prayson RA; Hamrahian AH; Weil RJ Pituitary; 2014 Apr; 17(2):103-8. PubMed ID: 23475513 [TBL] [Abstract][Full Text] [Related]
15. Comparative effectiveness review of treatment options for pituitary microadenomas in acromegaly. Marko NF; LaSota E; Hamrahian AH; Weil RJ J Neurosurg; 2012 Sep; 117(3):522-38. PubMed ID: 22725987 [TBL] [Abstract][Full Text] [Related]
16. The association between treatment and systemic inflammation in acromegaly. Wolters TLC; van der Heijden CDCC; Pinzariu O; Hijmans-Kersten BTP; Jacobs C; Kaffa C; Hoischen A; Netea MG; Smit JWA; Thijssen DHJ; Georgescu CE; Riksen NP; Netea-Maier RT Growth Horm IGF Res; 2021; 57-58():101391. PubMed ID: 33964727 [TBL] [Abstract][Full Text] [Related]
17. A prospective analysis of 151 cases of patients with acromegaly operated by one neurosurgeon: a follow-up of more than 23 years. Abbassioun K; Amirjamshidi M; Mehrazin A; Khalatbary I; Keynama M; Bokai H; Abdollahi M Surg Neurol; 2006 Jul; 66(1):26-31; discussion 31. PubMed ID: 16793431 [TBL] [Abstract][Full Text] [Related]